Professor | Bing Zhao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Bing Zhao
Contact Information	zhaobing@fudan.edu.cn
Language ability	Chinese, English
Province	Shanghai

Upload Avatar (500 x 500)

Name

Bing Zhao

Contact Information

zhaobing@fudan.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2009.09—2013.07 Bachelor's in Biotechnology: Henan Normal University 2013.09—2018.07 PhD in Biochemistry and Molecular Biology: Fudan University
Work Experience	2018.07—2021.08 Fudan University - Postdoctoral Researcher 2021.09—Present Fudan University - Junior Associate Researcher

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2009.09—2013.07 Bachelor's in Biotechnology: Henan Normal University
2013.09—2018.07 PhD in Biochemistry and Molecular Biology: Fudan University

Work Experience

2018.07—2021.08 Fudan University - Postdoctoral Researcher
2021.09—Present Fudan University - Junior Associate Researcher

Areas of Focus	Design of new biotechnological drugs based on protein structure-activity relationship Tumor immunotherapy Mechanism of coagulation system in tumor development
Publications	Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease, Wu M., Xia T., Li Y., Wang T., Yang S., Yu J., Liang Q., Shen T., Yu M., Zhao B., 2022 A novel oncotherapy strategy, direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer, Zhao B., Wu M., Hu Z., Wang T., Yu J., Ma Y., Wang Q., Zhang Y., Chen D., Li T., Li Y., Yu M, Wang H., Mo W., 2021 Thrombin is a therapeutic target for non-small cell lung cancer to inhibit vasculogenic mimicry formation, Zhao B., Wu M., Hu Z., Ma Y., Wang Q., Zhang Y., Li Y., Yu M., Wang H., Mo W., 2020 A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous Injection, Zhao B., Zhang Y., Huang Y., Yu J., Li Y., Wang Q., Ma Y., Song H., Yu M., Mo W., 2017

Areas of Focus

Design of new biotechnological drugs based on protein structure-activity relationship
Tumor immunotherapy
Mechanism of coagulation system in tumor development

Publications

Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease, Wu M., Xia T., Li Y., Wang T., Yang S., Yu J., Liang Q., Shen T.*, Yu M.*, Zhao B.*, 2022
A novel oncotherapy strategy, direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer, Zhao B.*, Wu M., Hu Z., Wang T., Yu J., Ma Y., Wang Q., Zhang Y., Chen D., Li T., Li Y., Yu M*, Wang H.*, Mo W.*, 2021
Thrombin is a therapeutic target for non-small cell lung cancer to inhibit vasculogenic mimicry formation, Zhao B., Wu M., Hu Z., Ma Y., Wang Q., Zhang Y., Li Y., Yu M., Wang H.*, Mo W.*, 2020
A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous Injection, Zhao B., Zhang Y., Huang Y., Yu J., Li Y., Wang Q., Ma Y., Song H., Yu M., Mo W.*, 2017

Protein Structure Biotechnological Drugs Structure-Activity Relationship Tumor Immunotherapy Coagulation System Tumor Development Cancer Drug Design Biochemistry

Xiaowei Zhang - Peking University

Guochao Wei - Peking University

Weibin Wang - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us